Population pharmacokinetics of recombinant factor VIII:C (ReFacto®) in adult HIV-negative and HIV-positive haemophilia patients

The safety and efficacy of B‐domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A

Jeanne M. Lusher, C. A. Lee, Craig M. Kessler et al. · Haemophilia · 2003 · 178 citations

A 6‐year follow‐up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia

Josefin Ahnström, Erik Berntorp, Karin Lindvall et al. · Haemophilia · 2004 · 146 citations

Population pharmacokinetics of racemic warfarin in adult patients

Dennis Mungall, Thomas M. Ludden, James D. Marshall et al. · Journal of Pharmacokinetics and Biopharmaceutics · 1985 · 104 citations

Thrombosis, Cardiovascular Disease, Hematology +7

Emerging viral diseases and infectious disease risks

Michael L. Tapper · Haemophilia · 2006 · 49 citations · Full text

Virus Epidemiology, New Pathogens, Virus Transmission +16

Medical Costs and Resource Utilization for Hemophilia Patients With and Without HIV or HCV Infection

T Tencer, Howard S. Frıedman, Josephine Li-McLeod et al. · Journal of Managed Care Pharmacy · 2007 · 45 citations · Full text